CoChat

U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines

Open access
Gubernot, Diane, Jazwa, Amelia, Niu, Manette, Baumblatt, Jane, Gee, Julianne, Moro, Pedro, Duffy, Jonathan, Harrington, Theresa, McNeil, Michael M., Broder, Karen, Su, John, Kamidani, Satoshi, Olson, Christine K., Panagiotakopoulos, Lakshmi, Shimabukuro, Tom, Forshee, Richard, Anderson, Steven, Bennett, Sarah · 2021 · Vaccine
Cited by 74

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The Coronavirus Disease 2019 (COVID-19) pandemic has had a devastating impact on global health, and has resulted in an unprecedented, international collaborative effort to develop vaccines to control the outbreak, protect human lives, and avoid further social and economic disruption. Mass vaccination campaigns are underway in multiple countries and are expected worldwide once more vaccine becomes available. Some early candidate vaccines use novel platforms, such as mRNA encapsulated in lipid nanoparticles, and relatively new platforms, such as replication-deficient viral vectors. While these new vaccine platforms hold promise, limited safety data in humans are available. Serious health outcomes linked to vaccinations are rare, and some outcomes may occur incidentally in the vaccinated population. Knowledge of background incidence rates of these medical conditions is a critical component of vaccine safety monitoring to aid in the assessment of adverse events temporally associated with vaccination and to put these events into context with what would be expected due to chance alone. A list of 22 potential adverse events of special interest (AESI), including neurologic, autoimmune, and cardiovascular disorders, was compiled by subject matter experts at the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention. The most recently available U.S. background rates for these medical conditions, overall and by age, sex, and race/ethnicity (when available), were sourced from reported statistics (data published by medical panels/ associations or federal government reports), and literature reviews in PubMed. This review provides estimates of background incidence rates for medical conditions that may be monitored or studied as AESI during safety surveillance and research for COVID-19 vaccines and other new vaccines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2021.05.016

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 74

Metadata

Authors
Gubernot, D., Jazwa, A., Niu, M., Baumblatt, J., Gee, J., Moro, P., Duffy, J., Harrington, T., McNeil, M. M., Broder, K., Su, J., Kamidani, S., Olson, C. K., Panagiotakopoulos, L., Shimabukuro, T., Forshee, R., Anderson, S., & Bennett, S.
Venue
Vaccine
Publisher
Elsevier BV
Published
2021-06
Volume
39
Issue
28
Pages
3666-3677
ISSN
0264-410X (ISSN-L)
OpenAlex
W3160661236
Cited by
74
References
9
FWCI
4.96
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. https://app.cochat.ai/papers/10.1016/j.vaccine.2021.05.016
The paper
Gubernot, D., Jazwa, A., Niu, M., Baumblatt, J., Gee, J., Moro, P., Duffy, J., Harrington, T., McNeil, M. M., Broder, K., Su, J., Kamidani, S., Olson, C. K., Panagiotakopoulos, L., Shimabukuro, T., Forshee, R., Anderson, S., & Bennett, S. (2021). U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. Vaccine. https://doi.org/10.1016/j.vaccine.2021.05.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.